Antigen-Driven Evolution of B Lymphocytes in Coronary Atherosclerotic Plaques

scientific article published on 27 July 2009

Antigen-Driven Evolution of B Lymphocytes in Coronary Atherosclerotic Plaques is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4049/JIMMUNOL.0901076
P698PubMed publication ID19635916

P50authorRoberto BurioniQ27058410
Nicola ClementiQ38321716
Massimo ClementiQ40337451
Filippo CanducciQ42411788
Nicasio ManciniQ56431915
Alaide ChieffoQ57047373
Domenico CianfloneQ117233440
Diego SaitaQ117270813
Donata De MarcoQ117270814
P2093author name stringAntonio Colombo
Attilio Maseri
Angelo A Manfredi
Mario Perotti
Maurizio Denaro
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectatherosclerosisQ12252367
P304page(s)2537-2544
P577publication date2009-07-27
P1433published inJournal of ImmunologyQ3521441
P1476titleAntigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques
P478volume183

Reverse relations

cites work (P2860)
Q36261019A Recombinant Human Anti-Platelet scFv Antibody Produced in Pichia pastoris for Atheroma Targeting
Q40665206Adaptive immunity against gut microbiota enhances apoE-mediated immune regulation and reduces atherosclerosis and western-diet-related inflammation
Q38417056Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections
Q64068510Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines
Q46306295Ancestral resurrection of anthropoid estrogen receptor β demonstrates functional consequences of positive selection.
Q38303799Anti-inflammatory effects of vinpocetine in atherosclerosis and ischemic stroke: a review of the literature.
Q51594134B-cell-specific depletion of tumour necrosis factor alpha inhibits atherosclerosis development and plaque vulnerability to rupture by reducing cell death and inflammation.
Q33574045Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention
Q31082179Cross-reacting antibacterial auto-antibodies are produced within coronary atherosclerotic plaques of acute coronary syndrome patients
Q38018062HCV proteins and immunoglobulin variable gene (IgV) subfamilies in HCV-induced type II mixed cryoglobulinemia: a concurrent pathogenetic role
Q30421884Lymphocytes and the adventitial immune response in atherosclerosis
Q36432725Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII).
Q92820698Opportunities for an atherosclerosis vaccine: From mice to humans
Q38774904Readapting the adaptive immune response - therapeutic strategies for atherosclerosis
Q27000791The role of T and B cells in human atherosclerosis and atherothrombosis

Search more.